Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of HMGN3 mRNA | affects expression | 21346803
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of HMGN3 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of HMGN3 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of HMGN3 mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
HMGN3 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of HMGN3 mRNA | increases expression | 16807920
|
D008713 |
Methimazole |
Methimazole results in decreased expression of HMGN3 mRNA | decreases expression | 17403546
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of HMGN3 mRNA | decreases expression | 17616710
|
D017239 |
Paclitaxel |
HMGN3 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
C041786 |
palm oil |
palm oil results in increased expression of HMGN3 mRNA | increases expression | 18042831
|
C494474 |
perchlorate |
perchlorate results in increased expression of HMGN3 mRNA | increases expression | 17403546
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HMGN3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011374 |
Progesterone |
Progesterone results in increased expression of HMGN3 mRNA | increases expression | 18070364
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of HMGN3 mRNA | decreases expression | 17403546
|
D019772 |
Topotecan |
HMGN3 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HMGN3 mRNA | increases expression | 17218384
|
D014747 |
Vinblastine |
HMGN3 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.56 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.47 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.53 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.87 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.06 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.33 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
15.33 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.33 | 16206674 16197459 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.70 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.55 | 15867366 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.34 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.24 | 15665606 15380490 15845082 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.79 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.35 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.35 | 17426702 15939500 15994142 16096432 16595493 18695136 17369602 15136595 16935488 18628466 15634643 19526202 18382427 16264153 11325840 15668708 17983394 18234424 15993339 15567936 16115903 16826403 16322301 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.35 | 18223236 16273361 11325840 16244791 16115903 18323546 18234424 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.35 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.35 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.77 | 15721981 16192424 15700767 3786805 16227642 16050911 15673190 18705752 16124888 16011737 16097048 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.81 | 16051944 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.86 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.86 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.86 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
8.86 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.86 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.92 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
6.92 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.76 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.76 | 16096774 16051514 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.51 | 16364871 17974986 15476868 16455267 17519947 16612575 17308081 17928571 16731534 17007740 16651473 15792986 16269455 17382496 15505089 16242529 17329180 16952015 16109756 15811867 17131338 17924179 17351982 16278810 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.08 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.52 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.52 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.70 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.66 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.65 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.65 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.65 | 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 9224671 10589399 8800419 17551590 9125849 16925845 9211117 14991402 9142499 9664655 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.00 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.48 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.26 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.26 | 6623471 10915739 19336974 21278145 10092053 2869522 3786805 9327722 6884620 15968718 7120509 4309450 3732212 17522070 7179309 16177239 11566570 19085960 15998439 7440962 15027814 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.26 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.65 | 18602426 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.44 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.46 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.47 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.76 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.54 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.54 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.75 | 16134523 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.16 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.91 | 16805852 15547733 15150132 16510608 16704527 15264214 15623463 15878914 15547721 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.91 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.56 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.61 | 16045604 12795759 17595544 12631006 19224547 15959796 61145 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.61 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
18.61 | 17967931 19551842 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.61 | 19236843 20131406 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
21.07 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
21.07 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
21.07 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
21.07 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.20 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.20 | 17312396 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.29 | 18801409 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.80 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.80 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.88 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.47 | 14766674 18674790 17875725 16330681 16879835 17888722 18006777 16244371 16495754 16707910 16244372 12587719 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.01 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.01 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.88 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.58 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.98 | 19176532 16221962 18467677 19772884 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.74 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
7.74 | 18501091 18180244 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.19 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.52 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.57 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.60 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.09 | 10903974 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.07 | 15338365 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.60 | 14678291 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
11.91 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
11.91 | 18031379 8137927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.39 | 15869954 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.15 | 20412841 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.15 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.20 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.20 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.88 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.07 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.07 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.13 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.21 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.21 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.76 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.16 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.68 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.14 | 16935935 19035177 17217047 17339181 16140955 17712046 15748426 17107899 16331271 16788101 16766008 17361223 17506722 16891316 17301526 9834237 17368321 19075265 19029980 19642359 12679006 16823087 19225113 17294898 17649720 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.80 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.59 | 16943688 16221502 11408273 21278145 11903743 17334410 16239168 17157831 17174718 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.59 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.95 | 18418968 16015684 17565644 15052691 16192424 15370692 12632512 17708605 17631135 18006644 16097048 15818738 16116963 12389079 18705752 18412020 15057751 18472094 17525996 18395914 17944888 18210741 18317297 17823541 15362042 17557913 12667390 15730626 18339082 12898905 17976157 14716496 18166357 18376398 16011737 12666154 15959796 15925388 18395095 17698563 18263696 14748882 14716833 12632514 17766677 16248980 12609069 15338365 15123356 12546737 17640975 14620537 20821823 17922224 16033810 17481882 17900296 15931870 12445421 18054572 11481614 14512876 13678700 18251166 18420326 17869086 15876570 12649538 18187930 18472332 12958196 17714472 14724832 18277467 18481824 17761835 15650968 16638106 18156304 15673190 15893842 12445418 18205269 16136751 12586293 17805973 18279442 18429990 12741479 10355542 16027843 15996030 17721639 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.95 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.95 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.95 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.08 | 16246199 16964402 15830285 15720792 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.15 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.67 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.35 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.35 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.35 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.83 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.83 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.83 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.14 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.44 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.90 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
8.90 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.55 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.19 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.19 | 17203775 11408345 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.36 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
7.36 | 12040289 12025231 16342250 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.36 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
7.36 | 17761969 16809738 16432458 15577323 18505091 18176117 16248763 15577320 12374674 18332650 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.05 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.48 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.78 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.67 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.07 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.68 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.68 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.93 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.85 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.10 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.10 | 15867366 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.87 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.87 | 16946489 16594593 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.75 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.23 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.23 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.76 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.04 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.26 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.26 | 15176712 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.55 | 17378895 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.42 | 19632207 21332399 20518802 17217161 16723640 11836018 18457598 20132043 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.42 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.41 | 16049721 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.97 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.09 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
7.95 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.95 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.95 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.88 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.45 | 15976015 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.16 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.16 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.61 | 15897917 16888761 16729912 16868541 18437689 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.61 | 17172428 17136230 16356831 16729912 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.21 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.08 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.85 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.97 | 18313854 15675481 17710206 16767912 17203757 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.23 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.78 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.52 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.86 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.86 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.55 | 17203757 15625365 16767912 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.27 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
3.51 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.51 | 18396642 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.51 | 17261132 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.80 | 16930453 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
12.02 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
12.02 | 15710170 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.02 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.16 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.16 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.66 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.03 | 15577323 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.21 | 17334414 16364871 17678736 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.72 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |